BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13

• Press Releases

  Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA

  February 12, 2026

   · 

  7 min read
• Press Releases

  Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance

  February 12, 2026

   · 

  15 min read
• Press Releases

  U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer

  February 12, 2026

   · 

  13 min read
• Press Releases

  NMD Pharma results from Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2 selected for late-breaking oral presentation at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

  February 12, 2026

   · 

  5 min read
• Press Releases

  Altasciences Announces Chris Perkin Appointed Executive Chairman; Marie-Hélène Raigneau Appointed Chief Executive Officer

  February 12, 2026

   · 

  5 min read
• Press Releases

  Nektar Therapeutics Announces Pricing of Upsized $400 Million Public Offering

  February 12, 2026

   · 

  6 min read
• Press Releases

  BioRestorative Announces Pricing of $5.0 Million Public Offering

  February 12, 2026

   · 

  5 min read
• Press Releases

  Zelluna ASA: Fourth Quarter 2025 – Key regulatory milestone achieved with CTA Submission

  February 12, 2026

   · 

  2 min read
• Press Releases

  Xilio Therapeutics Announces Pricing of Underwritten Offering

  February 12, 2026

   · 

  4 min read
• Press Releases

  Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results

  February 12, 2026

   · 

  1 min read